Spasticity is involuntary overactivity of muscles that occurs following upper motor neuron damage to the brain or spinal cord. Upper limb spasticity is common after stroke and can cause deformity, ...

Arbaclofen extended-release (ER) reduced spasticity in patients with multiple sclerosis and was found to be safe and well-tolerated, according to 2 new abstracts presented at the 33rd Annual Meeting ...

Spasticity most often develops in upper motor neuron types of injuries. It is a motor disorder defined as velocity dependent, increased resistance to passive muscle stretch. It is an exaggeration of ...

Investigators sought to determine the safety and efficacy of twice-daily dosing of arbaclofen ER in patients with spasticity due to multiple sclerosis. SEATTLE – Twice-daily arbaclofen ...

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced topline results for two double-blind phase III studies of Dysport® (abobotulinumtoxinA) in Pediatric Lower ...

Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...